Latest News

  • Alkermes Announces Initiation of FORWARD-5 Clinical Study of ALKS 5461 For Treatment of Major Depressive Disorder Read More
  • Alkermes to Host Conference Call to Discuss Second Quarter 2014 Financial Results Read More
  • Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 8700 for Treatment of Multiple Sclerosis Read More

Investors

Learn More

Working at Alkermes

Join Our Team